Litcius/Paper detail

Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study

Kenichi Kito, Hiroshi Nomoto, Ichiro Sakuma, AKINOBU NAKAMURA, Kyu Yong Cho, Hiraku Kameda, Aika Miya, Kazuno Omori, Shingo Yanagiya, Takahisa Handa, Shinji Taneda, Jun Takeuchi, So Nagai, Kumiko Yamashita, Yoshio Kurihara, Tatsuya Atsumi, HIDEAKI MIYOSHI

2022Diabetes Research and Clinical Practice16 citationsDOI

Topics & Concepts

MedicineHypertriglyceridemiaInternal medicineType 2 Diabetes MellitusEndocrinologyFenofibrateDiabetes mellitusFibrateType 2 diabetesGastroenterologyTriglycerideGlycemicCholesterolPeroxisome Proliferator-Activated ReceptorsDiabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders
Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study | Litcius